Expanding the Knowledge on Transthyretin p.V142I Variant-Related Cardiomyopathy
European Journal of Heart Failure · 2024
DOI: 10.1002/ejhf.3132 ↗Kurz gefasst
Editorial in der Zeitschrift European Journal of Heart Failure, 2024. Verfasst von Emanuele Monda und 1 weiteren Autor:innen. Beteiligte Einrichtung: Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania 'Luigi Vanvitelli', Monaldi Hospital…. Hauptthemen laut MEDLINE: Heart Failure, Cardiomyopathies, Amyloidosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania 'Luigi Vanvitelli', Monaldi Hospital, Naples, Italy.
- University College London, Institute of Cardiovascular Science, London, UK.
Zitieren
APA
Monda, E., & Limongelli, G. (2024). Expanding the Knowledge on Transthyretin p.V142I Variant-Related Cardiomyopathy. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.3132
Vancouver
Monda E, Limongelli G. Expanding the Knowledge on Transthyretin p.V142I Variant-Related Cardiomyopathy. European Journal of Heart Failure. 2024. doi:10.1002/ejhf.3132
BibTeX
@article{Monda2024,
author = {Monda, Emanuele and Limongelli, Giuseppe},
title = {Expanding the Knowledge on Transthyretin p.V142I Variant-Related Cardiomyopathy},
journal = {European Journal of Heart Failure},
year = {2024},
doi = {10.1002/ejhf.3132}
}
EUVIMED